TrialHuman vaccines & immunotherapeutics2020

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population.

Rebecca K Hollenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.